Clinical Trial Update: A Study to Assess Intranasal Repeat Dose Effect of Levocabastine in the Subjects With Allergic Rhinitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intranasal repeat-dose levocabastine in subjects with allergic rhinitis (perennial and seasonal); results were completed and posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Levocabastine (levocabastine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Perennial and Seasonal | Phase 2 | Status: COMPLETED | Results posted: 2014-09-25